Intai Technology Corp
Intai Technology Corp designs, develops, and distributes medical equipment and supplies, primarily serving the healthcare sector.
Business. Intai Technology Corp (4163.TWO) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is headquartered in Taiwan and is primarily listed on the Taiwan Premium Exchange (TPEx). Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Intai Technology Corp (4163.TWO) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is headquartered in Taiwan and is primarily listed on the Taiwan Premium Exchange (TPEx). Specific details regarding its operating segments and geographic revenue mix are not available.
Intai Technology Corp maintains a debt-to-equity ratio of 0.53, indicating a moderate reliance on debt financing, while its current ratio of 2.13 suggests reasonable short-term liquidity. The company's cash and equivalents of TWD 233.7 million are offset by long-term debt of TWD 1.43 billion, resulting in a net cash position that is negative after subtracting total debt. This liquidity profile is assessed as medium risk, with no immediate dilution pressure observed.
Profitability metrics show a return on equity (ROE) of 9.21% and a return on assets (ROA) of 5.15%, both below the industry median for medical equipment and supplies firms. The operating margin of 11.9% (calculated from operating income of TWD 286.1 million on revenue of TWD 2.41 billion) is also below the sector average, indicating room for improvement in cost control and pricing power.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes, particularly in the healthcare sector.
Revenue growth has been modest, with the most recent fiscal year reporting TWD 2.41 billion in revenue. While the company has maintained positive operating cash flow of TWD 458.7 million, capital expenditures of TWD 184.8 million have reduced free cash flow to TWD 60.2 million. The outlook for the next fiscal year remains neutral, with no significant revenue acceleration expected.
The risk assessment highlights liquidity as a medium concern, primarily due to the negative net cash position. Dilution risk is low, with no recent or planned share issuances identified. However, the company's reliance on long-term debt and the absence of a strong free cash flow position could limit its ability to fund growth initiatives without external financing.
Recent filings and transcripts have not disclosed any material events or strategic shifts. The company continues to focus on its core medical equipment and supplies business, with no new product lines or geographic expansions announced in the latest disclosures.
- Intai Technology Corp has a moderate debt load and a current ratio of 2.13, indicating acceptable short-term liquidity.
- The company's ROE of 9.21% and ROA of 5.15% are below the industry median, suggesting underperformance in asset utilization and profitability.
- Revenue is concentrated in a single business segment, with no geographic diversification disclosed, increasing exposure to regional risks.
- Free cash flow is limited at TWD 60.2 million, which may constrain the company's ability to invest in growth without external financing.
- No significant dilution risk is currently present, but the negative net cash position raises liquidity concerns.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Intai Technology Corp Market data — financials · 2026-05-26
- Intai Technology Corp Market data — analyst estimates · 2026-05-26